VBL Therapeutics to Present Late-Breaking Research at the American Association for Cancer Research (AACR) 2018 Annual Meeting on April 16

NEXT STORY
Achaogen Announces Multiple Plazomicin Presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
PREV STORY
Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County; Revenue Growth Through Acquisitions, Wholesale, and Retail Sales Channels All Multiply
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Data up to 8-years for Roche’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis

author_avatar
NASDAQ Market News

Novan’s NITRICIL™ Technology Shows In Vitro Antiviral Effect Against SARS-CoV-2 in Human Airway Infection Model

author_avatar
NASDAQ Market News

AB Science will host a live webcast on masitinib in severe asthma on Monday December 2, 2019

author_avatar
NASDAQ Market News